Information:
Fel:
ID
39686
Beskrivning
A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir; ODM derived from: https://clinicaltrials.gov/show/NCT02103699
Länk
https://clinicaltrials.gov/show/NCT02103699
Nyckelord
Versioner (1)
- 2020-02-10 2020-02-10 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
10 februari 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis C Virus NCT02103699
Eligibility Hepatitis C Virus NCT02103699
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C Virus NCT02103699
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Chronic Hepatitis C Genotype
Item
patients who have genotype 1 chronic hepatitis c infection
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C1533728 (UMLS CUI [1,2])
Hepatitis C virus RNA assay
Item
hepatitis c virus (hcv) ribonucleic acid (rna) test result above the limit of quantification before initiation of simeprevir-based therapy
boolean
C1272251 (UMLS CUI [1])
simeprevir
Item
health care provider decision to treat patient with a simeprevir-based therapy, inclusive of patients who have been treated with a simeprevir-based therapy for less than or equal to (<=) 28 days will be enrolled into the study
boolean
C2605855 (UMLS CUI [1])
Prior Therapy Completed Hepatitis C
Item
prior hcv treatment must be completed more than 3 months before initiation of simeprevir-based therapy
boolean
C1514463 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
Standard of Care Clinic Visits | Telemedicine
Item
in the opinion of the health care provider, the patient will attend routine standard of care visits, either at enrolled site or by virtual/telemedicine
boolean
C2936643 (UMLS CUI [1,1])
C0008952 (UMLS CUI [1,2])
C0162648 (UMLS CUI [2])
C0008952 (UMLS CUI [1,2])
C0162648 (UMLS CUI [2])
Absence Chronic Hepatitis C Genotype
Item
non-genotype 1 hcv infected patients
boolean
C0332197 (UMLS CUI [1,1])
C0524910 (UMLS CUI [1,2])
C1533728 (UMLS CUI [1,3])
C0524910 (UMLS CUI [1,2])
C1533728 (UMLS CUI [1,3])
Medical contraindication Component Hepatitis C treatment prescribed
Item
absolute contraindication to any component of prescribed hcv treatment per prescribing information
boolean
C1301624 (UMLS CUI [1,1])
C1705248 (UMLS CUI [1,2])
C2367818 (UMLS CUI [1,3])
C1705248 (UMLS CUI [1,2])
C2367818 (UMLS CUI [1,3])
Study Subject Participation Status | Interventional Study
Item
patient is currently enrolled in an interventional study
boolean
C2348568 (UMLS CUI [1])
C3274035 (UMLS CUI [2])
C3274035 (UMLS CUI [2])
HCV DIRECT ACTING ANTIVIRALS
Item
past use of an hcv direct-acting antiviral therapy
boolean
C0220847 (UMLS CUI [1,1])
C3653501 (UMLS CUI [1,2])
C3653501 (UMLS CUI [1,2])
Investigational New Drugs
Item
any investigational drug use within 30 days before initiation of simeprevir-based therapy
boolean
C0013230 (UMLS CUI [1])